Likewise, CD11b+ cells and CD11c+ cells were also reduced in the curcumin-treated group compared to the placebo group in the anti-GBM mouse model, but the difference was not statistically different (Figure 2C,D). This evidence concerns the gene ITGAX and glioblastoma.